-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HW8/SM0hOGWcS5KMgBV4ZoRfbQmrWGUVu7XfWPszmvdOVuJUnyPnSkB6MC1xmaI7 zQJDxroIQ76FbXGOFs9lYg== 0000950123-11-001264.txt : 20110107 0000950123-11-001264.hdr.sgml : 20110107 20110107105939 ACCESSION NUMBER: 0000950123-11-001264 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20110107 DATE AS OF CHANGE: 20110107 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MEDIWARE INFORMATION SYSTEMS INC CENTRAL INDEX KEY: 0000874733 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 112209324 STATE OF INCORPORATION: NY FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-41734 FILM NUMBER: 11516055 BUSINESS ADDRESS: STREET 1: 11711 WEST 79TH STREET CITY: LENEXA STATE: KS ZIP: 66214 BUSINESS PHONE: 9133071000 MAIL ADDRESS: STREET 1: 11711 WEST 79TH STREET CITY: LENEXA STATE: KS ZIP: 66214 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: AURIANA LAWRENCE CENTRAL INDEX KEY: 0000935404 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: 140 EAST 45TH STREET 43RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 SC 13D/A 1 c10564sc13dza.htm SCHEDULE 13D/A Schedule 13D/A

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934
(Amendment No. 18)*

Mediware Information Systems, Inc.
(Name of Issuer)
Common Stock, par value $.10 per share
(Title of Class of Securities)
584946107
(CUSIP Number)
Mr. Lawrence E. Auriana
145 East 45th Street
New York, NY 10012
(212) 922-2999
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
January 3, 2011
(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 


 

                     
CUSIP No.
 
584946107 
 

 

           
1   NAMES OF REPORTING PERSONS

Lawrence E. Auriana
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o 
  (b)   þ 
     
3   SEC USE ONLY
   
   
     
4   SOURCE OF FUNDS (SEE INSTRUCTIONS)
   
  SC
     
5   CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
   
  o
     
6   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  U.S.
       
  7   SOLE VOTING POWER
     
NUMBER OF   2,469,440
       
SHARES 8   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   None
       
EACH 9   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   None
       
WITH 10   SHARED DISPOSITIVE POWER
     
    None
     
11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  2,469,440
     
12   CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
   
  30.5%
     
14   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN


 

Lawrence E. Auriana hereby amends and supplements the Schedule 13D originally filed with the Securities and Exchange Commission (the “SEC”) on August 16, 1991, as amended by Amendment No. 1 filed with the SEC on July 10, 1996, by Amendment No. 2 filed with the SEC on January 6, 2000, by Amendment No. 3 filed with the SEC on January 22, 2001, by Amendment No. 4 filed with the SEC on February 8, 2002, by Amendment No. 5 filed with the SEC on February 7, 2003, by Amendment No. 6 filed with the SEC on July 22, 2003, by Amendment No. 7 filed with the SEC on November 7, 2003, by Amendment No. 8 filed with the SEC on February 6, 2004, by Amendment No. 9 filed with the SEC on May 6, 2004, by Amendment No. 10 filed with the SEC on December 9, 2004, by Amendment No. 11 filed with the SEC on October 7, 2005, by Amendment No. 12 filed with the SEC on June 12, 2006, by Amendment No. 13 filed with the SEC on March 5, 2008, by Amendment No. 14 filed with the SEC on March 23, 2009, by Amendment No. 15 filed with the SEC on August 4, 2009, by Amendment No. 16 filed with the SEC on January 12, 2010 and as further amended by Amendment No. 17 filed with the SEC on July 9, 2010 (the “Schedule”) as follows:
This Schedule relates to the common stock, par value $.10 per share (“Common Stock”), of Mediware Information Systems, Inc., a New York corporation (the “Company”).
Item 3. Source and Amount of Funds or Other Consideration.
Item 3 of the Schedule is hereby supplemented by inserting the following text as the last paragraph thereof:
“The acquisition of the 918 shares of Common Stock that are the subject of Amendment No. 18 to the Schedule were the subject of a grant of restricted stock to Mr. Auriana under the Company’s 2003 Equity Incentive Plan, as amended, on January 3, 2011. The subject shares vest on June 30, 2011 if Mr. Auriana continues to be a director of the Company at such date.”
Item 5. Interest in Securities of the Issuer.
Item 5(a) of the Schedule is hereby amended by deleting the existing text and inserting the following text in its stead:
“Mr. Auriana beneficially owns (as defined by Rule 13d-3 under the Securities Exchange Act of 1934, as amended) 2,469,440 shares, or 30.5% of the shares of Common Stock outstanding as of January 3, 2011. 67,500 of such shares are issuable pursuant to presently exercisable options under the Company’s stock option plans.”
Item 5(b) of the Schedule is hereby amended by deleting the existing text and inserting the following text in its stead:
“Mr. Auriana has sole voting power over 2,469,440 shares of Common Stock. Pursuant to a Discretionary Account at Sandgrain Securities Inc. (“Sandgrain”), Mr. Auriana has no investment power, including the power to dispose, or to direct the disposition of, any shares of Common Stock. See Item 6.”
Item 5(c) of the Schedule is hereby amended by deleting the existing text and inserting the following text in its stead:
“Except for the 918 shares of Common Stock acquired pursuant to the grant under the Company’s 2003 Equity Incentive Plan on January 3, 2011, there were no acquisitions of shares of Common Stock by Sandgrain for Mr. Auriana during the past sixty (60) days.”

 

 


 

SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
         
     
  /s/ Angelo Perrone    
  Angelo Perrone   
  Attorney-in-Fact   
 
Date: January 6, 2011

 

 

-----END PRIVACY-ENHANCED MESSAGE-----